• Latest Posts

What do the CAR-T Patient Deaths Mean for the Future of the Field?

Get to know 15 of the best biotech companies in Paris

Gene-Edited T Cell Therapy Players Battle Safety Doubts

European Cancer Deals Increasingly Focus on Natural Killer Cells

Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference


Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential

In Depth 11 Oct 2021

A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology

French Biotech Develops a New Generation of Safer CAR-T Cells

French CAR-T Developer Raises $164M Despite a Challenging Road

Another Huge Acquisition Sees CAR-T Stocks Jump – Except for Celyad

In Depth 17 Jan 2018

An Update on What’s New in the French Biotech Industry